Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
With over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications.
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
With deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
Creative Biolabs is one of the world’s leading contract organizations (CRO) that has extensive experience in preclinical drug discovery. Our employees are at the core of our success, with the ambition to improving health and increasing access to quality health solutions worldwide. We believe when curious, courageous and collaborative people like you are brought together, a big difference will be made for the development of innovate medicines.
Get a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
The Anti-HSA Protein A Scaffold molecule binds with high affinity to native albumin from human, mouse and rat serum. The Anti-HSA Protein A Scaffold molecule can be used as capture reagent or detection reagent in ELISA. It is also well suited for affinity chromatography and depletion of HSA from human serum. The Biotin-Conjugated Anti-HSA Protein A Scaffold molecule is biotinylated at a unique C-terminal cysteine using a maleimide-biotin reagent, facilitating immobilization on various streptavidin coated solid supports.
ELISA, Affinity chromatography.
Anti-HSA Protein A scaffold molecule binds to native human serum albumin (HSA) and also to serum albumin of mouse and rat origin.
Short-term storage at +4°C is recommended. For long-term storage, the protein solution should be aliquoted and then stored at -20°C. There is no decrease in performance of the biotinylated Protein A Scaffold molecule after 10 repeated freeze and thaw cycles or afte
Human serum albumin (HSA), a soluble, monomeric protein, is the most abundant protein in human serum. Normal levels are 40-60 mg/ml HSA in blood; however the amount of HSA decreases upon infection. HSA acts primarily as a carrier protein for steroids, fatty acids and thyroid hormones, and it stabilizes extracellular fluid volume. Serum albumin is produced by the liver as pre-proalbumin and it is cleaved twice before secretion.
Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.